A Clinical Study of DEB-TACE Combined With Surufatinib and Camrelizumab in the Treatment of Inoperable or Metastatic ICC
Clinical trial NCT05236699 · COMPLETED
Trial details
- NCT number
- NCT05236699
- Sponsor
- Tongji Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-01
- Primary completion
- 2024-06-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.